XML 53 R15.htm IDEA: XBRL DOCUMENT
v3.20.1

Earnings per Common Share | 3 Months Ended
--- | ---
Mar. 31, 2020
Earnings Per Share [Abstract] |
Earnings per Common Share | Earnings per Common Share The following table sets forth the computation of basic and diluted earnings per common share (in millions, except per share amounts):
| Three Months Ended March 31,
| 2020 |  | 2019
Basic: |  |  |
Numerator: |  |  |
Income from continuing operations | $ | 108.8 |  |  | $ | 125.7 |
Less: Net income attributable to noncontrolling interests included in continuing operations | (21.7 | ) |  | (22.9 | )
Less: Income allocated to participating securities | (0.3 | ) |  | (0.4 | )
Income from continuing operations attributable to Encompass Health common shareholders | 86.8 |  |  | 102.4 |
Loss from discontinued operations, net of tax, attributable to Encompass Health common shareholders | (0.1 | ) |  | (0.5 | )
Net income attributable to Encompass Health common shareholders | $ | 86.7 |  |  | $ | 101.9 |
Denominator: |  |  |
Basic weighted average common shares outstanding | 98.2 |  |  | 98.4 |
Basic earnings per share attributable to Encompass Health common shareholders: |  |  |
Continuing operations | $ | 0.88 |  |  | $ | 1.05 |
Discontinued operations | — |  |  | (0.01 | )
Net income | $ | 0.88 |  |  | $ | 1.04 |
Diluted: |  |  |
Numerator: |  |  |
Income from continuing operations | $ | 108.8 |  |  | $ | 125.7 |
Less: Net income attributable to noncontrolling interests included in continuing operations | (21.7 | ) |  | (22.9 | )
Income from continuing operations attributable to Encompass Health common shareholders | 87.1 |  |  | 102.8 |
Loss from discontinued operations, net of tax, attributable to Encompass Health common shareholders | (0.1 | ) |  | (0.5 | )
Net income attributable to Encompass Health common shareholders | $ | 87.0 |  |  | $ | 102.3 |
Denominator: |  |  |
Diluted weighted average common shares outstanding | 99.6 |  |  | 99.7 |
Diluted earnings per share attributable to Encompass Health common shareholders: |  |  |
Continuing operations | $ | 0.87 |  |  | $ | 1.04 |
Discontinued operations | — |  |  | (0.01 | )
Net income | $ | 0.87 |  |  | $ | 1.03 |
The following table sets forth the reconciliation between basic weighted average common shares outstanding and diluted weighted average common shares outstanding (in millions):
| Three Months Ended March 31,
| 2020 |  | 2019
Basic weighted average common shares outstanding | 98.2 |  |  | 98.4 |
Restricted stock awards, dilutive stock options, and restricted stock units | 1.4 |  |  | 1.3 |
Diluted weighted average common shares outstanding | 99.6 |  |  | 99.7 |
See Note 17, Earnings per Common Share, to the consolidated financial statements accompanying the 2019 Form 10‑K for additional information related to our common stock.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI http://asc.fasb.org/topic&trid=2144383 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration